Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Published Sep 20, 2022 17:41

Updated Sep 20, 2022 18:40

Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
  • Virax Biolabs Group Limited (NASDAQ: VRAX) gained 47.7% to $3.6493 after the company announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.
  • BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) shares gained 25.8% to $6.92. BYND Cannasoft shares jumped over 32% on Monday after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
  • TRxADE HEALTH, Inc. (NASDAQ: MEDS) jumped 24.7% to $1.3299 after the company announced Bonum Health, a subsidiary, signed a Telemedicine Services Distribution Deal with Wakefern Food, to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut and Maryland.
  • GigaCloud Technology Inc. (NASDAQ: GCT) gained 19.8% to $15.90.
  • Mobile Global Esports Inc. (NASDAQ: MGAM) shares gained 19.4% to $2.89 after gaining over 4% on Monday.
  • a.k.a. Brands Holding Corp. (NYSE: AKA) jumped 18.8% to $1.7112.
  • SeqLL Inc. (NASDAQ: SQL) gained 16.1% to $0.9333.
  • Renovacor, Inc. (NYSE: RCOR) jumped 14.7% to $2.1794. Rocket Pharmaceuticals agreed to acquire Renovacor in an all-stock transaction for an implied value of approximately $2.60 per share.
  • Amprius Technologies, Inc. (NYSE: AMPX) rose 13.5% to $6.70.
  • Studio City International Holdings Limited (NYSE: MSC) gained 13.5% to $2.3150.
  • Senti Biosciences, Inc. (NASDAQ: SNTI) rose 13% to $1.90 after gaining 5% on Monday.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) rose 12.2% to $0.96 after declining around 9% on Monday.
  • O2Micro International Limited (NASDAQ: OIIM) rose 10.2% to $3.25 after the company announced receipt of a revised preliminary non-binding proposal to acquire the company.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) gained 10% to $2.7301.
  • Melco Resorts & Entertainment Limited (NASDAQ: MLCO) rose 9.7% to $6.39.
  • AEA-Bridges Impact Corp. (NYSE: IMPX) gained 9.3% to $10.80.
  • Innoviz Technologies Ltd. (NASDAQ: INVZ) gained 8.9% to $6.03 after JP Morgan initiated coverage on the stock with an Overweight rating and announced a $22 price target.
  • Cognex Corporation (NASDAQ: CGNX) rose 8.3% to $45.17 as the company boosted its guidance for the third quarter.
  • bluebird bio, Inc. (NASDAQ: BLUE) jumped 8% to $6.41. Raymond James maintained bluebird bio with an Outperform and raised the price target from $8 to $10.
  • RLX Technology Inc. (NYSE: RLX) gained 6.8% to $1.25.
  • Oxford Industries, Inc. (NYSE: OXM) climbed 6.8% to $96.11. Oxford Industries completed the acquisition of Johnny Was, a California-based affordable luxury apparel brand, for $270 million. Piper Sandler maintained Oxford Industries with an Overweight and raised the price target from $130 to $135.
  • Change Healthcare Inc. (NASDAQ: CHNG) rose 6.7% to $27.18 after a U.S. judge denied the Justice Department's request to stop UnitedHealth (NYSE:UNH)'s $13 billion buyout deal for Change Healthcare.
  • Lyft , Inc. (NASDAQ: NASDAQ:LYFT) gained 5.6% to $17.16.
Losers
  • Virios Therapeutics, Inc. (NASDAQ: VIRI) fell 74.5% to $0.5079 after the company priced a 10 million share public offering at $0.50 per share. Also, HC Wainwright & Co downgraded the stock from Buy to Neutral.
  • Pagaya Technologies Ltd. (NASDAQ: PGY) shares tumbled 58.9% to $2.87 after dropping 11% on Monday.
  • Cosmos Holdings Inc. (NASDAQ: COSM) dropped 38.6% to $0.2271.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) dipped 24.6% to $0.7982 as the U.S. FDA staff raised concerns over the safety of the company’s experimental cancer drug and questioned the benefits it provided over existing therapies.
  • Tellurian Inc. (NYSE: TELL) fell 22.5% to $3.0231.
  • Winc, Inc. (NYSE: WBEV) fell 20.5% to $0.7154 after jumping around 27% on Monday.
  • FOXO Technologies Inc. (NYSE: FOXO) dropped 16.8% to $2.0799.
  • Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) fell 16.3% to $5.90 after climbing around 55% on Monday.
  • MicroCloud Hologram Inc (NASDAQ: HOLO) dropped 14.9% to $2.5101.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) fell 14.7% to $0.1439. Esports Entertainment recently priced a 30 million share plus warrant public offering at $0.25 per share plus warrant.
  • E-Home Household Service Holdings Limited (NASDAQ: EJH) fell 14% to $0.1333.
  • Sotera Health Company (NASDAQ: SHC) fell 13.7% to $8.50
  • CF Acquisition Corp. VI (NASDAQ: RUM) dipped 12.8% to $14.63.
  • Dawson Geophysical Company (NASDAQ: DWSN) fell 12.3% to $1.91.
  • Rockley Photonics Holdings Limited (NYSE: RKLY) dropped 11.8% to $1.0050.
  • Vericity, Inc. (NASDAQ: VERY) fell 9.6% to $6.60.
  • Ford Motor Company (NYSE: NYSE:F) fell 9.1% to $13.57 after the company previewed the effect of parts shortages on the company in the third-quarter and said inflation-related supplier costs during the third quarter will run about $1.0 billion higher than originally expected. The company also projects to have about 40,000 to 45,000 vehicles in inventory at end of third quarter lacking certain parts presently in short supply.
  • Vor Biopharma Inc. (NASDAQ: VOR) dropped 7.2% to $4.27.
  • Aravive, Inc. (NASDAQ: ARAV) fell 7.1% to $0.9473.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) fell 6.4% to $1.15. Clovis Oncology recently submitted applications for Rubraca label expansion in the US and European Union as first-line maintenance treatment in women with advanced ovarian cancer.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

Read the original article on Benzinga

Written By: Benzinga

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes